Shellac- a natural carrier for colon targeting of indomethacin using hot melt extrusion

References

• Granados-Romero JJ, Valderrama-Treviño AI, Contreras-Flores EH, et al. Colorectal cancer: a review. Int J Res Med Sci. 2017;5(11):4667.
   Google Scholar
• Gala UH, Miller DA, Williams RO. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochim Biophys Acta BBA - Rev Cancer. 2020;1873:188319.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Sung B, Prasad S, et al. Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol Sci. 2013;34:508–517.
   PubMed Web of Science ®Google Scholar
• Wang H-M. Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo. WJG. 2005;11(3):340.
   PubMed Web of Science ®Google Scholar
• Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994;54(21):5602–5606.
   Google Scholar
• Hull MA, Gardner SH, Hawcroft G. Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. Cancer Treat Rev. 2003;29:309–320.
   PubMed Web of Science ®Google Scholar
• Yang C, Zhang Y, Cai P, et al. Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy. J Drug Target. 2020;28(1):102–110.
   PubMed Web of Science ®Google Scholar
• Asghar LFA, Chure CB, Chandran S. Colon Specific Delivery of Indomethacin: Effect of Incorporating pH Sensitive Polymers in Xanthan Gum Matrix Bases. AAPS PharmSciTech. 2009;10:418–429.
   PubMed Web of Science ®Google Scholar
• Fernández-Hervás MJ, Fell JT. Pectin/chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int J Pharm. 1998;169(1):115–119.
   Web of Science ®Google Scholar
• Akhgari A, Afrasiabi Garekani H, Sadeghi F, et al. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm. 2005;305:22–30.
   PubMed Web of Science ®Google Scholar
• Akhgari A, Sadeghi F, Garekani H. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm. 2006;320:137–142.
   PubMed Web of Science ®Google Scholar
• Ibekwe VC, Liu F, Fadda HM, et al. An Investigation into the In Vivo Performance Variability of pH Responsive Polymers for Ileo-Colonic Drug Delivery Using Gamma Scintigraphy in Humans. J Pharm Sci. 2006;95:2760–2766.
   PubMed Web of Science ®Google Scholar
• Bruce LD, Shah NH, Waseem Malick A, et al. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur J Pharm Biopharm. 2005;59:85–97.
   PubMed Web of Science ®Google Scholar
• Balogh A, Farkas B, Domokos A, et al. Controlled-release solid dispersions of Eudragit® FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion. Eur Polym J. 2017;95:406–417.
   Web of Science ®Google Scholar
• Edueng K, Mahlin D, Larsson P, et al. Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways. J Controlled Release. 2017;256:193–202.
   PubMed Web of Science ®Google Scholar
• Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007;33(9):909–926.
   PubMed Web of Science ®Google Scholar
• Kinget R, Kalala W, Vervoort L, et al. Colonic drug targeting. J Drug Target. 1998;6:129–149.
   PubMed Web of Science ®Google Scholar
• Zhang F. Melt-extruded eudragit® FS-based granules for colonic drug delivery. AAPS PharmSciTech. 2016;17:56–67.
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731–741.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Thombare N. Safety assessment of shellac as food additive through long term toxicity study. Trends Biosci. 2017;10:733–740.
   Google Scholar
• Sharma SK, Shukla SK, Vaid DN. Shellac-Structure, Characteristics & Modification. DSJ. 1983;33(3):261–271.
   Google Scholar
• Buch K, Penning M, Wächtersbach E, et al. Investigation of various shellac grades: additional analysis for identity. Drug Dev Ind Pharm. 2009;35:694–703.
   PubMed Web of Science ®Google Scholar
• Farag Y, Leopold CS. Physicochemical properties of various shellac types. Dissolution Technol. 2009;16(2):33–39.
   Web of Science ®Google Scholar
• Kapote DN, Wagner KG. Influence of shellac on the improvement of solubility and supersaturation of loratadine amorphous solid dispersion using a new grade of HPMC. J Drug Deliv Sci Technol. 2021;61:102116.
   Web of Science ®Google Scholar
• Gupta SS, Solanki N, Serajuddin ATM. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: AffinisolTM HPMC HME polymers. AAPS PharmSciTech. 2016;17:148–157.
   PubMed Web of Science ®Google Scholar
• Huang S, O’Donnell KP, Keen JM, et al. A new extrudable form of hypromellose: AFFINISOLTM HPMC HME. AAPS PharmSciTech. 2016;17:106–119.
   PubMed Web of Science ®Google Scholar
• Sun DD, Lee PI. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. J Controlled Release. 2015;211:85–93.
   PubMed Web of Science ®Google Scholar
• Monschke M, Kayser K, Wagner KG. Processing of polyvinyl acetate phthalate in hot-melt extrusion—preparation of amorphous solid dispersions. Pharmaceutics. 2020;12(4):337.
   Web of Science ®Google Scholar
• Goodman GA, Goodman LS. Analgesics-antipyretics; pharmacotherapy of gout. New York: Mcgraw Hill; 2006.
   Google Scholar
• Denninger A, Westedt U, Rosenberg J, et al. A rational design of a biphasic dissolution setup—modelling of biorelevant kinetics for a ritonavir hot-melt extruded amorphous solid dispersion. Pharmaceutics. 2020;12(3):237.
   Web of Science ®Google Scholar
• Steffens KE, Wagner KG. Improvement of tabletability via twin-screw melt granulation: focus on binder distribution. Int J Pharm. 2019;570:118649.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1997;14(12):1691–1698.
   PubMed Web of Science ®Google Scholar
• Ewing AV, Clarke GS, Kazarian SG. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging. Eur J Pharm Sci. 2014;60:64–71.
   PubMed Web of Science ®Google Scholar
• Tang XLC, Pikal MJ, Taylor LS. The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers. Pharm Res. 2002;19(4):484–490.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Li T, Taylor LS. Estimation of drug–polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res. 2009;26:139–151.
   PubMed Web of Science ®Google Scholar
• Tian B, Zhang L, Pan Z, et al. A comparison of the effect of temperature and moisture on the solid dispersions: Aging and crystallization. Int J Pharm. 2014;475:385–392.
   PubMed Web of Science ®Google Scholar